Cagrilintide, an amylin analogue, is a promising medication for weight loss by enhancing satiety, delaying gastric emptying, and suppressing appetite. In my patients, I have also seen increased In the REDEFINE 2 phase 3a trial involving adults with obesity and diabetes, the use of cagrilintidesemaglutide resulted in a significantly lower body weight than placebo at 68 weeks. Full trial results Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity New England Journal of Medicine Clinical trials of subcutaneous tirzepatide, retatrutide, and Download Scientific Diagram Cagrilintide 10mg Tirzepatide Australia